Regulatory policy and pharmaceutical innovation in the United Kingdom after Brexit: Initial insights

Brexit was presented as an opportunity to promote innovation by breaking free from the European Union regulatory framework. Since the beginning of 2021 the Medicines and Healthcare products Regulatory Agency (MHRA) has operated as the independent regulatory agency for the United Kingdom. The MHRA�...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofer, Matthias P., Criscuolo, Paola, Shah, Nilay, ter Wal, Anne L. J., Barlow, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797847/
https://www.ncbi.nlm.nih.gov/pubmed/36590956
http://dx.doi.org/10.3389/fmed.2022.1011082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797847/
https://www.ncbi.nlm.nih.gov/pubmed/36590956
http://dx.doi.org/10.3389/fmed.2022.1011082

Ejemplares similares